Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
<p>Abstract</p> <p>Background</p> <p>Despite its frequent use as a hypnotic, trazodone has not been systematically assessed in fibromyalgia patients. In the present study have we evaluated the potential effectiveness and tolerability of trazodone in the treatment of fib...
Main Authors: | Morillas-Arques Piedad, Ma Rodriguez-Lopez Carmen, Molina-Barea Rocio, Rico-Villademoros Fernando, Calandre Elena P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/11/204 |
Similar Items
-
Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study
by: Rodriguez-Lopez Carmen M, et al.
Published: (2011-05-01) -
Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study
by: Einstein Francisco Camargos, et al.
Published: (2011-02-01) -
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
by: Rico-Villademoros Fernando, et al.
Published: (2009-11-01) -
Psychiatric Comorbidity in Children and Adults with Gluten-Related Disorders: A Narrative Review
by: Mahmoud Slim, et al.
Published: (2018-07-01) -
Estimation of an Appropriate Dose of Trazodone for Pediatric Insomnia and the Potential for a Trazodone–Atomoxetine Interaction
by: Laura Oggianu, et al.
Published: (2020-02-01)